We describe a case of absence-like electrographic seizures during NREM sleep in a patient who was taking sodium oxybate, a sodium salt of γ-hydroxybutyric acid (GHB). An overnight full montage electroencephalography (EEG) study revealed numerous frontally predominant rhythmic 1.5-2 Hz sharp waves and spike-wave activity during stage N2 and N3 sleep at the peak dose time for sodium oxybate, resembling atypical absence-like electrographic seizures. The patient was later weaned off sodium oxybate, and a repeat study did not show any such electrographic seizures. Absence-like seizures induced by GHB had previously been described in experimental animal models. We present the fi rst reported human case of absence-like electrographic seizure associated with sodium oxybate. Keywords: seizure, narcolepsy, pharmacology Citation: Cheung J, Lucey BP, Duntley SP, Darken RS. γ-hydroxybutyric acid-induced electrographic seizures. J Clin Sleep Med 2014;10(7):811-812.http://dx.doi.org/10.5664/jcsm.3882 C A S E R E P O R T S γ -hydroxybutyric acid (GHB) is the active ingredient of sodium oxybate and is approved by the Food and Drug Administration for the treatment of cataplexy associated with narcolepsy. GHB and γ-butyrolactone, a prodrug of GHB, have been shown to reliably increase slow wave sleep as well as induce absence-like seizures accompanied by 3-6 Hz spikewave discharges (SWD) in monkeys and rats. GHB is regarded as the best pharmacological model of typical absence seizures in animal models.1-4 To our knowledge, there has not been a reported case of GHB-induced absence-like seizure in a human.
REPORT OF CASEThe patient was a 35-year-old man who had narcolepsy with cataplexy as well as obstructive sleep apnea (OSA). He had been taking sodium oxybate for 2 years. The patient had no history of seizures, and his neurological examination was normal.A full-montage electroencephalography (EEG) polysomnography (PSG) was obtained, as the patient's wife reported abnormal sleep behaviors including somnambulism, sleep eating, somniloquy, and possible dream enactment. The patient took sodium oxybate 4.5 g with two separate doses for a total of 9 g on the night of the study as he would regularly at night. His PSG showed moderate-severe OSA with an apnea hypopnea index (AHI) of 29.4 respiratory events per hour of sleep. Additionally, the full-montage EEG revealed > 10 4-10 second runs of rhythmic frontally predominant 100-150 µV, 1.5-2 Hz sharp waves and spike-wave complexes during stage N2 and N3 sleep over a period of ~30 minutes (Figure 1). The EEG was otherwise unremarkable. On video review, no abnormal behavior was associated with the epileptiform activity. He was noted to have frequent somniloquy during REM and NREM, with large movements during REM, as well as REM without atonia meeting criteria for REM sleep behavior disorder. However, these episodes were not associated with the runs of spike-wave A brain magnetic resonance imaging (MRI) was later obtained and was normal. A routine daytime EEG including hyperventilation and phot...